Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 211-218

  Hetland, Geir ^a   Wiker, Harald G ^a   Høgåsen, Kolbjørn ^a   Hamasur, Beston ^b   Svenson, Stefan B ^b   Harboe, Morten ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EGTAZIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; LIPOARABINOMANNAN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0031924388     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.2.211-218.1998     Document Type: Article

References (34)

1. Bardana, E. J., Jr., J. K. McClatchy, R. S. Farr, and P. Minden. 1973. Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin. Exp. Immunol. 13:65-77.
2. Bermundez, L. E., L. S. Young, and H. Enkel. 1991. Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins. Infect. Immun. 59:1697-1702.
3. Braathen, L. R., A. Bratlie, and P. Teisberg. 1986. HLA genotypes in a family with a case of homozygous C2 deficiency and discoid lupus erythematosus. Acta Dermato-Venereol. 66:419-422.
4. Bullock, W. E., and S. D. Wright. 1987. Role of the adherence promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165:195-210.
5. Christensen, O., K. Bjartveit, and G. Dahlstrom. 1978. Tuberculosis situation in the Scandinavian countries. Scand. J. Respir. Dis. Suppl. 102:19-40.
6. Costello, A. M., A. Kumar, V. Narayan, M. S. Akbar, S. Ahmed, C. AbouZeid, G. A. Rook, J. Stanford, and C. Moreno. 1992. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans. R. Soc. Trop. Med. Hyg. 86:686-692.
7. Cywes, C., N. L. Godenir, H. C. Hoppe, R. R. Scholle, L. M. Steyn, R. E. Kirsch, and M. R. W. Ehlers. 1996. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64:5373-5383.
8. Da Costa, C. T., S. Khaolkar-Young, A. M. Elliott, K. M. Wasunna, and K. P. McAdam. 1993. Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin. Exp. Immunol. 91:25-29.
9. Fine, P. E., and the Karonga Prevention Trial Group. 1996. Randomized controlled trial of single BCG, repeated BCG, or combined BCG plus killed Mycobacterium leprae vaccine, for prevention of leprosy and tuberculosis in Malawi. Lancet 348:17-24.
10. Garred, P., H. O. Madsen, B. Hofmann, and A. Svejgaard. 1995. Increased frequency of homozygosity of abnormal mannan-binding-protein-gene alleles in patients with suspected immunodeficiency. Lancet 346:941-943.
11. Garred, P., T. E. Mollnes, and T. Lea. 1988. Quantification in enzyme-linked immunosorbent assay of a C3 neocpitope expressed on activated human complement factor C3. Scand. J. Immunol. 27:329-335.
12. Gaynor, C. D., F. X. McCormack, D. R. Voelker, S. E. McGowan, and L. S. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155:5343-5351.
13. Hamasur, B., and S. B. Svenson. Unpublished data.
14. Hetland, G., and H. G. Wiker. 1994. Antigen 85C on Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products. Immunology 82:445-449.
15. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Scrum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451-7454.
16. Kawasaki, T., R. Etoh, and I. Yamashina. 1978. Isolation and characterization of a mannan-binding protein in association with a novel C1s-like serine protease. Biochem. Biophys. Res. Commun. 81:1018-1024.
17. Kuhlman, M., K. Joiner, and R. A. B. Ezekowitz. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1733-1745.
18. Launois, P., M. Niang, A. Dieye, J. L. Sarthou, F. Rivier, and J. Millan. 1992. Human phagocyte respiratory burst by Mycobacterium bovis BCG and M. leprae: functional activation by BCG is mediated by complement and its receptors on monocytcs. Int. J. Lepr. Mycobacterial Dis. 60:225-233.
19. Malhotra, R., S. Thiel, K. B. M. Reid, and R. B. Sim. 1990. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J. Exp. Med. 172:955-959.
20. Michaelsen, T. E., P. Garred, and A. Aase. 1991. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration. Eur. J. Immunol. 21:11-16.
21. Mollnes, T. E., T. Lea, S. S. Frøland, and M. Harboe. 1985. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand. J. Immunol. 22:197-202.
22. Mollnes, T. E., H. Redl, K. Høgåsen, A. Bengtsson, P. Garred, L. Speilberg, T. Lea, M. Oppermann, O. Götze, and G. Schlag. 1993. Complement activation in septic baboons detected by neocpitope-specific assays for C3b/iC3b/ C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin. Exp. Immunol. 91:295-300.
23. Nagai, S., H. G. Wiker, M. Harboe, and M. Kinimoto. 1991. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect. Immunol. 59:372-382.
24. Perlmutter, R. M., D. Hansburg, D. E. Briles, R. A. Nicoletti, and J. M. Davie. 1978. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:566-572.
25. Podack, E. R., W. P. Kolb, and H. J. Müller-Eberhard. 1978. The C5b-9 complex: formation, isolation and inhibition of its activity by lipoprotein and the S-protein of human scrum. J. Immunol. 120:1841-1848.
26. 3 on human monocytes and monocyte-derived macrophages. Infect. Immun. 61:663-670.
27. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2780.
28. Schlesinger, L. S., and M. A. Horwitz. 1991. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J. Exp. Med. 174:J031-1038.
29. Schlesinger, L. S., and M. A. Horwitz. 1994. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immun. 62:280-289.
30. Stokes, R. W., I. D. Haidl, W. A. Jefferies, and D. P. Speert. 1993. Mycobacteria-macrophage interactions: macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J. Immunol. 151:7067-7076.
31. Stokes, R. W., and D. P. Speert. 1995. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol. 155:1361-1369.
32. Venisse, A., J.-M. Berjeaud, P. Chaurand, M. Gilleron, and G. Puzo. 1993. Structural features of lipoarabinomannan from Mycobacterium bovis BCG. J. Biol. Chem. 268:12401-12411.
33. Wiker, H. G., S. Nagai, M. Harboe, and L. Lundqvist. 1992. A family of cross-reactive proteins secreted by Mycobacterium tuberculosis. Scand J. Immunol. 36:307-319.
34. Wiker, H. G., S. Nagai, R. G. Hewinson, W. P. Russell, and M. Harboe. 1996. Heterogenous expression of the related MBP70 and MBP83 proteins distinguish various suhstrains of Mycobacterium bovis, BCG and Mycobacterium tuberculosis H37Rv. Scand. J. Immunol. 43:374-380.